Crawford Investment Counsel’s Allergan plc AGN.PRA Stock Holding History

Crawford Investment Counsel’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,132	Closed	-$1.25M	–	264
2017 Q4	$1.25M	Buy	2,132 +560	+36%	+$361K	0.04%	151
2017 Q3	$1.15M	Buy	1,572 +210	+15%	+$174K	0.04%	156
2017 Q2	$1.18M	Buy	1,362 +435	+47%	+$365K	0.04%	149
2017 Q1	$785K	Buy	927 +17	+2%	+$14.1K	0.03%	171
2016 Q4	$693K	Buy	910 +80	+10%	+$60.5K	0.03%	180
2016 Q3	$682K	Buy	+830	New	+$717K	0.03%	181

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Crawford Investment Counsel's AGN.PRA Position: Q1 2018 in Review

Crawford Investment Counsel sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 2,132 shares — an estimated $1.25M sold.

Crawford Investment Counsel first reported a position in AGN.PRA in Q3 2016 and held it in 6 quarters. The position peaked at $1.25M in Q4 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Crawford Investment Counsel reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Crawford Investment Counsel sold 2,132 Allergan plc shares in Q1 2018, an estimated $1.25M.
Crawford Investment Counsel first reported a position in Allergan plc in Q3 2016 and held it in 6 quarters.
Crawford Investment Counsel's Allergan plc position peaked at $1.25M in Q4 2017.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Crawford Investment Counsel's 13F filing for Q1 2018, filed 15 May 2018.